Mona Awad Alonazi, Amina El Gezeery, Afaf el-Ansary and Ramesa Shafi Bhat* Pages 1 - 6 ( 6 )
Background: In utero exposure to Selective serotonin reuptake inhibitors (SSRI) is considered as a risk factor for many neurodevelopmental diseases.
Objective: The aim of this study was to investigate whether prenatal SSRI exposure changes newborn brain chemistry.
Method: An animal based study was designed in which utero SSRI exposed rat’s pups were compared to one without drug exposure. Neurochemical changes of the infants were assessed after 2 days of birth by estimating the levels of inflammatory cytokines, neurotransmitters and caspases in the brain exposed to SSRI at prenatal stage and compared to normal unexposed newborn.
Results: Our results showed significant neurochemical changes in SSRI-exposed newborns. A significant decrease in dopamine, and serotonin levels; with a remarkable decrease in noradrenaline in addition to remarkable increase of IFN-γ and caspase-3 levels was observed in the brain tissues of prenatal exposed SSRIs rat pups.
Conclusion: The results suggest that prenatal SSRI treatment may affect brain development of newborn hence should be used warily during gestation period.
Depression, neurotransmitters, pro-inflammatory cytokines, caspases, brain
Biochemistry Department, College of Science, King Saud University, Biochemistry Department, College of Science, King Saud University, Central Laboratory, Female Centre for Scientific and Medical Studies, King Saud University, Biochemistry Department, College of Science, King Saud University